VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

BSC® Insights

Two abstracts have been accepted for presentation at the 2021 SLEEP annual meeting

Insights

1 min read time

BSC team members David Maislin and Brendan Keenan supported Dr. Victoria Pak (Emory University) in two abstracts examining the impact of CPAP on inflammatory biomarkers and whether obesity modifies the effect. The abstracts have been accepted for presentation at the 2021 SLEEP annual meeting https://www.sleepmeeting.org/. The conference will be held online from 10 to 13 June 2021.

The two approved abstracts are:

  1. "Obesity does not modify the effect of 4 months of CPAP on leptin or adiponectin"

  2. "Obesity modifies the effect of 4 months of CPAP on glucose levels in adults with obstructive sleep apnea"

Congrats to all authors:

Victoria M. Pak, David Maislin, Brendan Keenan, Raymond R. Townsend, Bryndis B. Benediktsdottir, Xiaofeng Guo, Allan I. Pack, Thorarinn Gislason, Samuel T. Kuna

Stay tuned!

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.